Presently, many of Sweden's 20,000 Parkinson's patients are not receiving the treatment they need, and many of the most seriously ill receive incorrect or inappropriate therapy. With the new Manage PD tool and the PD Pal ...
Nov 15, 2021
0
3
Lithium profoundly prevents the aggregation of toxic proteins and cell loss associated with Parkinson's disease (PD) in a mouse model of the condition.
Jun 24, 2011
0
1
Testing whether a new drug impacts the progression of Parkinson's disease takes years, in part because the disease often advances so slowly. Many Parkinson's patients don't have any worsening of their symptoms over the course ...
Nov 10, 2022
0
18
(HealthDay)—It's a connection few have probably considered, but new research suggests that having your appendix removed may up your risk for Parkinson's disease down the road.
May 9, 2019
0
105
New research shows that the number of people with Parkinson's disease will soon grow to pandemic proportions. In a commentary appearing today in the journal JAMA Neurology, University of Rochester Medical Center neurologist ...
Nov 13, 2017
0
115
When a patient experiences the first symptoms of Parkinson's disease, the disease has been developing for a long time, and the patient may have already lost half of a specific type of nerve cells in the brain.
Apr 25, 2023
0
68
University of Iowa researchers have confirmed in a new study that a specific region in the brain is critical to governing the mind's communication with the body's motor control system. The findings could yield advances in ...
Jul 26, 2022
0
299
Although there is a growing trend to involve patients in clinical research, specific guiding principles for engaging individuals with Parkinson's disease have not been established. The authors of this Call to Action published ...
May 11, 2022
0
2
At least half of Parkinson's disease patients experience psychosis at some point during the course of their illness, and physicians commonly prescribe antipsychotic drugs, such as quetiapine, to treat the condition. However, ...
Mar 21, 2016
0
39
Mutations in the LRRK2 gene are the most common cause of genetic Parkinson's disease (PD). New research published in BioMed Central's open access journal Molecular Neurodegeneration demonstrates that loss of function of LRRK2 ...
May 29, 2012
0
0
